The global Valsartan API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Valsartan(CAS?137862-53-4) is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease.
Valsartan API Market aims to provide a comprehensive presentation of the global market for Valsartan API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan API. Valsartan API Market contains market size and forecasts of Valsartan API in global, including the following market information:
- Global Valsartan API Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Valsartan API Market Sales, 2018-2023, 2024-2030, (Kg)
- Global top five Valsartan API companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Above 98 % Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Valsartan API include Biophore India Pharmaceuticals Pvt Ltd, Dr. Reddy's Laboratories, NEWEDGE Overseas, Suanfarma, Summit Pharmaceuticals Europe Srl, Octavius Pharma Pvt. Ltd, Synaptics Labs, Ami Lifesciences Private Limited and Zhuhai Rundu Pharmaceutical Co.,Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Valsartan API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Valsartan API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Kg)
Global Valsartan API Market Segment Percentages, by Type, 2022 (%)
Global Valsartan API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Kg)
Global Valsartan API Market Segment Percentages, by Application, 2022 (%)
Global Valsartan API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Kg)
Global Valsartan API Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Valsartan API revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Valsartan API revenues share in global market, 2022 (%)
- Key companies Valsartan API sales in global market, 2018-2023 (Estimated), (Kg)
- Key companies Valsartan API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Biophore India Pharmaceuticals Pvt Ltd
- Dr. Reddy's Laboratories
- NEWEDGE Overseas
- Suanfarma
- Summit Pharmaceuticals Europe Srl
- Octavius Pharma Pvt. Ltd
- Synaptics Labs
- Ami Lifesciences Private Limited
- Zhuhai Rundu Pharmaceutical Co.,Ltd
- Zhejiang Tianyu Pharmaceutical
- Menovo Pharmaceutical Co Ltd
- Sun Pharma
- Mylan
- Cadila Pharmaceuticals
- Mankind Pharma
- Zhejiang Huahai Pharmaceutical
- Ipca Laboratories
- Zhejiang Hisun Pharmaceutical
- DEAFARMA
- CHEMO
- Laurus Labs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Valsartan API, market overview.
Chapter 2: Global Valsartan API market size in revenue and volume.
Chapter 3: Detailed analysis of Valsartan API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Valsartan API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Valsartan API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Industry Market Size
